A Case Report: Considerable changes of serum FSH, LH and E-2 in respon
se to hormonal treatment were recorded in a patient with resistant-ova
ry syndrome during one year of observation. The FSH levels ranged init
ially from 28 to 180 IU/l; after treatment leuproreline (Lpr) and HMG,
respectively, they decreased to 5 to 12 IU/l. Serum E, reacted to inj
ections of HMC with a marked increase, but the amplitude of the respon
se diminished in subsequent treatment cycles. After one year of observ
ation, the patient ovulated spontaneously several times. Conclusion: T
he resistant-ovary syndrome is a variant of premature menopause charac
terised by a normal supplement of unresponsive follicles which may, ho
wever, termporarily regain normal function.